Testing the Effect of Raltegravir on Persistent de Novo HIV Infection in Virologic Responders to Antiretroviral Therapy
NCT02611895
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
120
Enrollment
OTHER
Sponsor class
Conditions
HIV-1 Infection
Interventions
BIOLOGICAL:
HIV DNA
Sponsor
University Hospital, Montpellier
Collaborators
[object Object]